C19orf18 encompass a diverse group of compounds that can induce a spectrum of intracellular signaling pathways leading to its activation. 6-Benzylaminopurine, a plant hormone, initiates a cascade of cellular events that promote cell division and growth, which can activate C19orf18 as it participates in these processes. Forskolin directly stimulates adenylate cyclase to raise cyclic AMP (cAMP) levels, thereby activating protein kinase A (PKA), which in turn may phosphorylate C19orf18. Similarly, dibutyryl-cAMP, a cell-permeable cAMP analog, can also trigger PKA or exchange protein activated by cAMP (EPAC), potentially leading to the activation of C19orf18. Phorbol 12-myristate 13-acetate (PMA) is known for activating protein kinase C (PKC), which has a broad role in cell signaling and may phosphorylate C19orf18 as part of its signaling cascade. Ionomycin acts by increasing intracellular calcium levels, thereby activating calcium-dependent kinases or phosphatases that may target C19orf18 within calcium signaling pathways. Isoproterenol, a beta-adrenergic agonist, stimulates adenylyl cyclase through G-protein coupled receptor signaling, which could also lead to the activation of C19orf18 through cAMP-mediated pathways.
Retinoic acid regulates gene expression through its receptors, potentially impacting C19orf18 as part of its signaling mechanism. Insulin, through the PI3K/Akt pathway, initiates a series of phosphorylation events that can culminate in the activation of C19orf18, linking it to metabolic control mechanisms. Anisomycin acts as a stress inducer, activating stress-activated protein kinases such as JNK, which may phosphorylate and hence activate C19orf18. Bradykinin, engaging with its G-protein-coupled receptor, can initiate phospholipase C (PLC) activation, increasing intracellular calcium and activating PKC, potentially leading to the phosphorylation of C19orf18 within the inflammatory response. Sphingosine-1-phosphate, through its receptor, may activate downstream kinases that phosphorylate C19orf18 as part of lipid signaling. In a similar vein, Ouabain, Thapsigargin, and A23187 all manipulate intracellular calcium levels, which can activate C19orf18 via calcium-dependent kinases. Hydrogen peroxide, as a reactive oxygen species, may modulate kinase and phosphatase activity, leading to the activation of C19orf18 through redox signaling. Endothelin-1, via its receptor, can trigger signaling involving PKC or MAPKs that may lead to the activation of C19orf18, while Lithium chloride and Sodium orthovanadate operate through the inhibition of enzymes like GSK-3 and phosphatases, respectively, which can result in the phosphorylation and subsequent activation of C19orf18.
SEE ALSO...
Items 1 to 10 of 15 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $52.00 | ||
6-Benzylaminopurine, a cytokinin plant hormone, can activate C19orf18 by stimulating cell division and growth pathways in which C19orf18 may be involved, leading to its functional activation as part of the cellular growth response. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which may phosphorylate C19orf18 as part of signal transduction, leading to its functional activation within cellular signaling pathways that rely on PKC. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent kinases or phosphatases that may target C19orf18, resulting in its activation as part of calcium signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist which activates adenylyl cyclase via G-protein coupled receptor signaling, potentially leading to C19orf18 activation through downstream cAMP-mediated pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression via retinoic acid receptors which can lead to the activation of downstream signaling molecules, potentially including C19orf18, as part of retinoic acid signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases like JNK, which may phosphorylate C19orf18, resulting in its functional activation as part of the stress response pathway. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that can permeate cell membranes and activate PKA or EPAC, which could subsequently phosphorylate and activate C19orf18 within the cAMP signaling pathway. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin binds to its G-protein-coupled receptor and can activate PLC, leading to increased intracellular calcium and activation of protein kinase C, which may phosphorylate and activate C19orf18 as part of the inflammatory response. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate binds to its G-protein-coupled receptor, potentially activating downstream kinases that could phosphorylate and activate C19orf18 within lipid signaling pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain binds to the Na⁺/K⁺-ATPase pump, leading to an increase in intracellular calcium, which may activate calmodulin-dependent kinases that could phosphorylate and activate C19orf18 as part of ion homeostasis signaling. | ||||||